Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: A retrospective chart review

Clinical Therapeutics

Volumn 22, Issue 12, 2000, Pages 1516-1524

  Brashear, Allison ^a   Watts, Maureen Wooten ^b   Marchetti, Albert ^c   Magar, Raf ^c   Lau, Helen ^c   Wang, Liping ^c  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Neurological Clinic of Texas   (United States)

^c Health Economics Research   (United States)

Author keywords

Botulinum toxin type A; Cervical dystonia; Duration of effect; Retrospective chart review

Indexed keywords

BOTULINUM TOXIN A; NEUROTOXIN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NECK MUSCLE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SHOULDER PAIN;

EID: 0034528086     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)83049-0     Document Type: Article

References (26)

1. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
2. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
3. Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia
4. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
5. Botulinum toxin type B: An open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients
6. Botulinum toxin type A: From toxin to therapeutic agent
7. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
8. Use of botulinum toxin in the treatment of cervical dystonia
9. Botulinum toxin treatment of spasmodic torticollis
10. Botulinum A toxin in spasmodic torticollis
11. Modification of muscle activity after BOTOX injections in spasmodic torticollis
12. Botulinum A toxin for the treatment of adultonset spasmodic torticollis
13. Low dose botulinum toxin in spasmodic torticollis
14. Local treatment of spasmodic torticollis with botulinum toxin
15. Botulinum toxin in spasmodic torticollis
16. Local treatment of spasmodic torticollis with botulinum toxin
17. A pilot study on the use of botulinum toxin in spasmodic torticollis
18. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
19. ® manufactured from a new bulk toxin in the open label treatment of cervical dystonia
20. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study
21. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia
22. Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: Results in 33 patients [in Portuguese]
23. Cervical Dystonia Severity Scale (CDSS) reliability study
24. ® for the treatment of cervical dystonia
25. ® (botulinum toxin type A) purified neurotoxin complex for the treatment of cervical dystonia
26. Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A